Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 7
Review
ALK-driven tumors and targeted therapy: focus on crizotinib
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,663 | Dovepress* | 8,801+ | 2,304 | 11,105 | |
| PubMed Central* | 2,862 | 863 | 3,725 | ||
| Totals | 11,663 | 3,167 | 14,830 | ||
|
*Since 20 March 2014 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 2 | 6 |
View citations on PubMed Central and Google Scholar